2025 Peptide Research Trends: What to Watch This Year

The peptide research landscape is evolving faster than ever. As we move through 2025, several trends are reshaping the field — some building on established work, others representing genuinely new directions. Here's what we're watching.

1. Multi-Agonist Metabolic Peptides

The evolution from mono-agonists (semaglutide) to dual-agonists (tirzepatide) to triple-agonists (retatrutide) represents a paradigm shift in metabolic research. Researchers are increasingly studying how targeting multiple receptor systems simultaneously affects metabolic outcomes, and early published data on triple-agonist compounds has generated significant excitement.

Expect to see more research on survodutide (GLP-1/glucagon dual agonist), mazdutide (oxyntomodulin analog), and novel combinations like cagrilintide + semaglutide that pair GLP-1 signaling with amylin pathways.

2. Mitochondrial Medicine Goes Mainstream

Mitochondrial-targeted therapies are moving from niche academic interest to mainstream research priority. SS-31, MOTS-c, and related compounds are being studied across an expanding range of contexts, from exercise physiology to neurodegenerative research. The recognition that mitochondrial dysfunction underpins many age-related conditions is driving substantial funding into this area.

3. AI-Designed Peptide Sequences

Machine learning is revolutionizing peptide design. AI models trained on millions of protein structures can now predict peptide-receptor interactions with remarkable accuracy, enabling researchers to design novel sequences with predicted biological activity. This computational approach is dramatically accelerating the discovery pipeline.

4. Peptide-Drug Conjugates (PDCs)

Inspired by antibody-drug conjugates in oncology, researchers are exploring peptides as targeted delivery vehicles. By conjugating therapeutic payloads to peptides that bind specific receptors, researchers can potentially achieve tissue-targeted delivery with reduced off-target effects.

5. Oral Peptide Delivery

Historically, peptides required injection due to degradation in the GI tract. New formulation technologies — including permeation enhancers, nanoparticle encapsulation, and protease-resistant analogs — are making oral peptide delivery increasingly viable. Oral semaglutide paved the way, and more oral peptide formulations are in development.

6. Epigenetic Peptides

Research on peptides that influence epigenetic modifications — changes in gene expression without altering DNA sequence — is gaining momentum. Epithalon's studied effects on telomerase expression sit at this intersection, and newer compounds are being designed to target specific epigenetic pathways.

7. Regulatory Evolution

The regulatory landscape around research peptides continues to evolve. Researchers should stay informed about FDA guidance, state-level regulations, and international frameworks that may affect compound availability and research protocols.

Looking Forward